文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

线粒体功能障碍介导脓毒症相关脑病的研究进展

[Research advances in mitochondrial dysfunction-mediated sepsis-associated encephalopathy].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2025-01-01
一句话结论脓毒症相关脑病的线粒体功能障碍机制涉及氧化应激失衡、能量代谢紊乱和凋亡信号激活,线粒体靶向干预尚处于临床前阶段。

脓毒症相关脑病(SAE)是脓毒症并发症之一,可导致从轻度注意力缺陷到昏迷的认知功能障碍,严重损害患者生活能力和心理健康,并增加长期残疾率和死亡率。尽管近年临床对SAE的关注增加,但改善脓毒症幸存者认知功能障碍的有效干预仍处于临床前阶段。SAE发病机制复杂,线粒体功能障碍作为关键致病机制之一,通过氧化应激失衡、能量代谢紊乱和凋亡信号通路激活参与认知障碍发展。本综述系统整合近年线粒体功能障碍在认知障碍发展中的研究,讨论线粒体结构破坏、线粒体动力学异常、呼吸链功能障碍,并总结线粒体靶向抗氧化剂、线粒体自噬激活剂、线粒体生物合成调节剂等新型干预策略在改善SAE患者认知功能中的研究进展,旨在为突破SAE临床治疗现状和靶向线粒体治疗提供理论依据。

要点

  • SAE是脓毒症并发症,认知障碍可从轻度注意力缺陷进展至昏迷,增加长期残疾率和死亡率。
  • 线粒体功能障碍是SAE关键致病机制之一,通过氧化应激失衡、能量代谢紊乱和凋亡信号通路激活参与认知障碍。
  • SAE中线粒体异常涉及线粒体结构破坏、线粒体动力学异常和呼吸链功能障碍。
  • 线粒体靶向抗氧化剂、线粒体自噬激活剂、线粒体生物合成调节剂等新型干预策略在改善SAE认知功能方面已有研究。
  • 改善脓毒症幸存者认知功能障碍的有效干预目前仍处于临床前阶段。

适用人群与场景

  • 脓毒症患者,认知功能障碍可从轻度注意力缺陷进展至昏迷。

研究设计与关键结果

  • 本综述系统整合近年线粒体功能障碍在SAE认知障碍发展中的研究,讨论线粒体结构破坏、线粒体动力学异常、呼吸链功能障碍,以及线粒体靶向抗氧化剂、线粒体自噬激活剂、线粒体生物合成调节剂等新型干预策略的研究进展。

证据类型、等级与局限

  • 证据类型:综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,线粒体功能障碍作为SAE关键致病机制之一,靶向线粒体治疗可能为突破SAE临床治疗现状提供理论依据。
  • 改善脓毒症幸存者认知功能障碍的有效干预目前仍处于临床前阶段。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Sepsis-associated encephalopathy (SAE) is one of the complications of sepsis, causes cognitive dysfunction ranging from mild attention deficits to progression into coma, which severely impairs patients' ability to live and mental health, and increases the long-term disability and mortality rates. Although the clinical attention to SAE has been increasing in recent years, effective interventions to improve cognitive dysfunction in sepsis survivors are still in the preclinical stage. The pathogenesis of SAE is numerous and complex, and mitochondrial dysfunction, as one of the key pathogenic mechanisms, plays a role in the cognitive development process through oxidative stress imbalance, energy metabolism disorders, and activation of apoptosis signaling pathway. The present review systematically integrates the recent studies on mitochondrial dysfunction in the development of cognitive disorders. This review systematically integrates the cutting-edge research results in recent years, discusses the mitochondrial structural disruption, mitochondrial kinetic abnormalities, respiratory chain dysfunction, and comprehensively comprehends the research progress of mitochondria-targeted antioxidant, mitochondrial autophagy activator, mitochondrial biosynthesis modifier and other novel intervention strategies in improving cognitive function of SAE patients, with the aim of providing theoretical basis for the breakthrough of the current status of clinical treatment of SAE and the targeting of mitochondria for treatment. The aim is to provide theoretical basis for breaking through the status of SAE clinical treatment and targeting mitochondrial therapy.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Zhang X, Zhang Y, Zhang B, et al. [Research advances in mitochondrial dysfunction-mediated sepsis-associated encephalopathy]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 41146514. doi:10.3760/cma.j.cn121430-20250213-00126

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。